Abortion Pill Maker Appeals To Supreme Court To Preserve Access After Lower Court Restrictions

The manufacturer of the abortion pill mifepristone has asked the Supreme Court to review restrictions imposed by a lower court ruling.
The restrictions include barring telemedicine prescriptions and mail delivery of mifepristone.
The Biden administration has also appealed to defend the existing federal approval of mifepristone, deemed safe and effective by medical organizations.
The Supreme Court's decision, expected by early summer 2024, will determine nationwide access to medication abortion.
This is the most high-profile abortion case since Roe v. Wade was overturned, carrying implications for reproductive rights.